Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,103,181
-$729,235 QoQ
Shares Held
16,647
-18.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#814
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Snowden Capital Advisors LLC holds $146,228,358 across 13 Drug Manufacturers - General names. GILD ranks #10 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,065 | $32,462,575 | |
| 2 | ABBV |
AbbVie Inc.
|
120,256 | $30,261,219 | |
| 3 | JNJ |
Johnson & Johnson
|
109,396 | $27,783,302 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,291 | $18,669,893 | |
| 5 | AMGN |
Amgen Inc
|
39,480 | $14,296,497 | |
| 6 | AZN |
Astrazeneca PLC
|
42,309 | $8,022,632 | |
| 7 | NVS |
Novartis AG
|
22,603 | $3,542,342 | |
| 8 | PFE |
Pfizer Inc
|
125,051 | $3,011,228 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,103,181 | 16,647 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,832,416 | 20,323 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,419,819 | 19,715 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,972,470 | 17,770 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,910,955 | 17,236 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,246,938 | 20,053 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,027,336 | 21,948 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,629,269 | 67,143 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,406,106 | 107,945 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,982,922 | 95,330 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,865,435 | 84,748 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,332,504 | 84,501 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,876,416 | 89,223 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,501,234 | 90,409 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,397,331 | 97,814 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,119,709 | 99,201 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $6,108,929 | 98,834 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,605,124 | 94,283 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,721,958 | 78,804 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $766,254 | 10,970 | Shares | Sole | 2024-02-06 | |
| 2021-06-30 | $738,730 | 10,728 | Shares | Sole | 2024-01-08 | |
| 2021-03-31 | $355,529 | 5,501 | Shares | Sole | 2024-01-08 | |
| 2020-12-31 | $244,633 | 4,199 | Shares | Sole | 2024-01-08 | |
| 2020-09-30 | $707,222 | 11,192 | Shares | Sole | 2024-01-08 | |
| 2020-06-30 | $773,323 | 10,051 | Shares | Sole | 2024-01-08 | |
| 2020-03-31 | $403,853 | 5,402 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||